Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Octocog alpha (liposomal)

EU orphan designation number: EU/3/09/655
Active ingredient: Octocog alpha (liposomal)
Indication: Treatment of haemophilia A
Sponsor: Bayer Schering Pharma AG
D-13342 Berlin, Deutschland

   Public summary of scientific opinion    


European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/07/2009 Centralised Orphan - Designation EMEA/OD/018/09 (2009)6032 of 24/07/2009
26/06/2013 Centralised Orphan - Removal of orphan designation from Community Register